SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001773427-21-000003
Filing Date
2021-05-05
Accepted
2021-05-05 16:48:44
Documents
49
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q swtx-20210331.htm   iXBRL 10-Q 1214428
2 EX-31.1 swtx-20210331xex3111.htm EX-31.1 11483
3 EX-31.2 swtx-20210331xex3121.htm EX-31.2 11502
4 EX-32.1 swtx-20210331xex3211.htm EX-32.1 5665
5 EX-32.2 swtx-20210331xex3221.htm EX-32.2 5671
  Complete submission text file 0001773427-21-000003.txt   3964351

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20210331.xsd EX-101.SCH 20117
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT swtx-20210331_cal.xml EX-101.CAL 55268
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT swtx-20210331_def.xml EX-101.DEF 86090
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20210331_lab.xml EX-101.LAB 308255
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20210331_pre.xml EX-101.PRE 184818
11 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20210331_htm.xml XML 509288
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39044 | Film No.: 21894170
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences